George Massaro Net Worth

The estimated Net Worth of George Massaro is at least $7.67 Milione dollars as of 15 May 2024. Mr. Massaro owns over 332 units of Charles River Laboratories International stock worth over $1,133,469 and over the last 21 years he sold CRL stock worth over $6,207,521. In addition, he makes $328,606 as Independent Director at Charles River Laboratories International.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Massaro CRL stock SEC Form 4 insiders trading

George has made over 90 trades of the Charles River Laboratories International stock since 2005, according to the Form 4 filled with the SEC. Most recently he sold 332 units of CRL stock worth $78,226 on 15 May 2024.

The largest trade he's ever made was exercising 16,710 units of Charles River Laboratories International stock on 3 November 2014 worth over $696,306. On average, George trades about 2,055 units every 50 days since 2004. As of 15 May 2024 he still owns at least 5,855 units of Charles River Laboratories International stock.

You can see the complete history of Mr. Massaro stock trades at the bottom of the page.

George Massaro biography

George E. Massaro is an Independent Director of Charles River Laboratories International Inc. He Director and Vice Chairman of Huron Consulting Group, Inc., a management consulting company, since May 2010. Mr. Massaro was non-Executive Chairman of the Board of Huron Consulting Group from July 2009 to May 2010, Director and Vice Chairman of Huron Consulting Group since June 2004 (Vice Chairman since March 2005), Chief Operating Officer of Huron Consulting Group, Inc. and Huron Consulting Services LLC from June 2003 until March 2005, and Managing Director of Huron Consulting Services LLC from August 2002 to May 2003. He was the Managing Partner of Arthur Andersen LLP's New England practice from 1998 to 2002. Mr. Massaro also served as a director of Eastern Bank Corporation, an independent mutual bank holding company in New England from 2003 through 2017. Mr. Massaro has been a director since 2003. Mr. Massaro has more than 35 years of accounting and auditing experience with expertise in a broad range of areas. As a former managing partner of a major accounting firm, Mr. Massaro brings a deep knowledge of financial reporting, and auditing and tax matters applicable to a variety of industries. Mr. Massaro also provides business acumen from his numerous senior positions at Huron Consulting, as well as his service on boards of other companies. As a result of his extensive background in public accounting and prior experience at Arthur Andersen, Mr. Massaro qualifies as an "audit committee financial expert" under SEC guidelines.

What is the salary of George Massaro?

As the Independent Director of Charles River Laboratories International, the total compensation of George Massaro at Charles River Laboratories International is $328,606. There are 11 executives at Charles River Laboratories International getting paid more, with James Foster having the highest compensation of $17,722,100.

How old is George Massaro?

George Massaro is 72, he's been the Independent Director of Charles River Laboratories International since 2003. There are 3 older and 18 younger executives at Charles River Laboratories International. The oldest executive at Charles River Laboratories International Inc. is Stephen Chubb, 76, who is the Independent Director.

Insiders trading at Charles River Laboratories International

Over the last 21 years, insiders at Charles River Laboratories International have traded over $220,588,205 worth of Charles River Laboratories International stock and bought 18,392 units worth $3,841,397 . The most active insiders traders include James C Foster, Richard F Wallman e David P Johst. On average, Charles River Laboratories International executives and independent directors trade stock every 14 days with the average trade being worth of $2,223,188. The most recent stock trade was executed by Joseph W La Plume on 8 August 2024, trading 1,780 units of CRL stock currently worth $354,861.

What does Charles River Laboratories International do?

charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro

Complete history of Mr. Massaro stock trades at Huron Consulting Inc e Charles River Laboratories International

Charles River Laboratories International executives and stock owners

Charles River Laboratories International executives and other stock owners filed with the SEC include:

• James Foster,
  Chairman of the Board, President, Chief Executive Officer
• David Smith,
  Chief Financial Officer, Corporate Executive Vice President
• James C. Foster,
  Chairman, CEO & Pres
• Joseph LaPlume,
  Corporate Executive Vice President, Corporate Development and Strategy
• Birgit Girshick,
  Corporate Executive Vice President, Global Discovery and Safety Assessment, Biologics and Avian
• William Barbo,
  Corporate Executive Vice President and Chief Commercial Officer
• David Ross Smith,
  Corp. Exec. VP & CFO
• William D. Barbo,
  Chief Commercial Officer & Corp. Exec. VP
• Joseph W. LaPlume,
  Corp. Exec. VP of Corp. Devel. & Strategy
• Birgit Girshick,
  Corp. Exec. VP & COO
• George Milne,
  Lead Independent Director
• George Massaro,
  Independent Director
• Robert Bertolini,
  Independent Director
• Richard Reese,
  Independent Director
• Richard Wallman,
  Independent Director
• Martin Mackay,
  Independent Director
• Deborah Kochevar,
  Independent Director
• Jean-Paul Mangeolle,
  Independent Director
• Stephen Chubb,
  Independent Director
• Virginia Wilson,
  Independent Director
• Nancy Andrews,
  Independent Director
• George Llado,
  Director
• Matthew L. Daniel,
  Corp. Sr. VP, Gen. Counsel, Corp. Sec. & Chief Compliance Officer
• Todd Spencer,
  Corp. VP of Investor Relations
• Mark Mintz,
  Corp. Sr. VP & Chief Information Officer
• Prof. Julie Frearson Ph.D.,
  Corp. Sr. VP & Chief Scientific Officer
• Michael Gunnar Knell,
  Corp. Sr. VP & Chief Accounting Officer
• John J Crowley,
  SVP, Chief Accounting Officer
• Davide Molho,
  Corporate Executive VP
• Michael Gunnar Knell,
  CSVP&Chief Accounting Officer
• Craig B. Thompson,
  Director
• John W Kuo,
  CEVP General Counsel & CCO
• Victoria L Creamer,
  EVP & Chief People Officer
• David P Johst,
  Corporate Executive VP
• Jorg Geller,
  OFFICERS
• Nancy Gillett,
  Vice President
• Thomas F Ackerman,
  Sr. Vp and CFO
• Samuel O Md Thier,
  Director
• William Waltrip,
  Director
• Nancy T Chang,
  Director
• Christopher Berthoux,
  OFFICERS
• Douglas E Rogers,
  Director
• Real H Renaud,
  Executive Vice President
• Brian Bathgate,
  Corporate Vice President
• Joanne P Acford,
  Corp. Sr VP, GC and Corp. Sec
• David J Elliott,
  Officer
• Linda Mc Goldrick,
  Director
• Stephanie B Wells,
  Senior Vice President
• Cheri L Walker,
  Corporate Senior VP
• Nicholas Ventresca,
  Senior Vice President
• Michael F Ankcorn,
  Corporate Sr. Vice President
• Walter S Nimmo,
  Director
• S Louise Mccrary,
  Director
• John C Ho,
  Senior Vice President
• Alastair Stuart Mcewan,
  Corporate Vice President
• John Urquhart,
  Director
• Dennis R Shaughnessy,
  Sr. VP Corporate Development
• Robert Cawthorn,
  Director
• Flavia Pease,
  Corporate Executive VP & CFO
• Shannon M Parisotto,
  CEVP, Disc & Safety Assessment
• Reshema Kemps Polanco,
  Director